Cart summary

You have no items in your shopping cart.

ERD-1233

SKU: orb2802562

Description

ERD-1233 is a potent, orally bioavailable PROTAC that selectively degrades the estrogen receptor with a DC50 of 0.9 nM. It is a valuable chemical tool for investigating ERα biology and is used in both in vitro and in vivo studies of ER-positive breast cancer.

Research Area

Metabolism Research, Pharmacology & Drug Discovery

Images & Validation

Key Properties

MW807.98
FormulaC49H53N5O6
TargetPROTACs,Estrogen Receptor/ERR

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • ER ligand-9 [orb2945117]

    3026011-20-8

    467.599

    C31H33NO3

    10 mg, 50 mg
  • ER ligand-8 [orb2945268]

    2229713-97-5

    654.584

    C30H27F9O4S

    50 mg, 10 mg
  • RR-11055 [orb2802337]

    3026009-09-3

    356.38

    C18H20N4O4

    50 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

ERD-1233 (orb2802562)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%